Internal Revenue Service
Revenue Ruling

TaxLinks.com   sm

Rev. Rul. 2003-58
Rev. Rul. 2003-58, 2003-22 I.R.B. 959, 2003-1 C.B. 959
                       Internal Revenue Service (I.R.S.)
                                 Revenue Ruling
                                MEDICAL EXPENSES
                             Released: May 15, 2003
                             Published: June 2, 2003

   Medical expenses. This ruling holds that amounts paid by an individual for medicines that may be purchased without a prescription of a physician are not deductible under section 213 of the Code, but amounts paid by an individual for equipment, supplies, or diagnostic devices that may be purchased without a prescription of a physician may be deductible under section 213.

  Medical expenses. Uncompensated amounts paid by individuals for medicines or drugs that may be purchased without a prescription of a physician are not deductible under section 213 of the Code. Amounts paid for equipment, supplies, or diagnostic devices may be expenses for medical care deductible under section 213.

ISSUES

  (1) Are amounts paid by an individual for medicines that may be purchased without a prescription of a physician deductible under s 213 of the Internal Revenue Code?

  (2) Are amounts paid by an individual for equipment, supplies, or diagnostic devices that may be purchased without a prescription of a physician deductible under s 213?

FACTS

  Taxpayer A has an injured leg and uses crutches to enhance mobility while the leg is healing. A uses bandages to cover torn skin on the leg. A's physician recommends that A take aspirin to treat pain in the leg. A also has diabetes and uses a blood sugar test kit to monitor A's blood sugar level. A is not compensated for these expenses by insurance or otherwise.

LAW AND ANALYSIS

  Section 213(a) allows a deduction for expenses paid during the taxable year, not compensated for by insurance or otherwise, for medical care of the taxpayer, spouse, or dependent, to the extent the expenses exceed 7.5 percent of adjusted gross income. Under s 213(d)(1), medical care includes amounts paid for the diagnosis, cure, mitigation, treatment, or prevention of disease, or for the purpose of affecting any structure or function of the body.

  Section 213(b) permits an amount paid for a medicine or drug to be taken into account for purposes of the s 213 deduction for medical care expenses only if the medicine or drug is a prescribed drug or insulin. Section 213(d)(3) defines a prescribed drug as a drug or biological that requires a prescription of a physician for its use by an individual. Because aspirin is a drug and does not require a physician's prescription for use by an individual, pursuant to s 213(b), its cost may not be taken into account under s 213, even if a physician recommends its use to a patient. Accordingly, A may not deduct the cost of the aspirin under s 213.

  However, s 213(b) does not apply to items that are not medicines or drugs, including equipment such as crutches, supplies such as bandages, and diagnostic devices such as blood sugar test kits. Such items may qualify as medical care if they otherwise meet the definition in s 213(d)(1). In this case, the crutches and bandages mitigate the effect of A's injured leg and the blood sugar test kit monitors and assists in treating A's diabetes. Therefore, the costs of these items are amounts paid for medical care under s 213(d)(1) and are deductible, subject to the limitations of s 213.

HOLDINGS

  (1) Amounts paid by an individual for medicines or drugs that may be purchased without a prescription of a physician are not taken into account pursuant to s 213(b) and are not deductible under s 213.

  (2) Amounts paid by an individual for equipment, supplies, or diagnostic devices may be expenses for medical care deductible under s 213 (subject to the other limitations of that section).

DRAFTING INFORMATION

  The principal author of this revenue ruling is John T. Sapienza, Jr., of the Office of Associate Chief Counsel (Income Tax and Accounting). For further information regarding this revenue ruling, contact Mr. Sapienza at (202) 622- 7900 (not a toll-free call).

 Rev. Rul. 2003-58, 2003-22 I.R.B. 959, 2003-1 C.B. 959